Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

20 results
Display

A clinical effect of retreatment by prothionamide, cycloserine, para-aminosalicylic acid, streptomycin(kanamycin or tuberactinomyc-in) on pulmonary tuberculosis

Shin CS, Im YJ, Kim YJ, Koh SS, Kim MS

  • KMID: 1699816
  • Tuberc Respir Dis.
  • 1992 Apr;39(2):167-171.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Cycloserine-Induced Lichenoid Drug Eruption Supported by the Lymphocyte Transformation Test

Kim J, Park S, Jung CM, Oh CW, Kwon JW

Lichenoid drug eruption (LDE) is a rare form of delayed-type drug eruption. Among anti-tuberculosis (Tb) agents, cycloserine (CS) has been reported as a rare cause of LDE. Positive results on...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
DRESS (drug reaction with eosinophilia and systemic symptom) syndrome caused by both first-line and second-line antitubercular medications: A case report with a brief literature review

Hwang YH, Jang DY, Kang SY, Sohn KH, Kang DY, Lee CH, Kang HR

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but potentially fatal drug-induced systemic hypersensitivity response characterized by erythematous eruption, fever, leukocytosis with eosinophilia, and internal organ...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Medical Treatment of Pulmonary Multidrug-Resistant Tuberculosis

Shim TS, Jo KW

Treatment of multidrug-resistant tuberculosis (MDR-TB) is challenging because of the high toxicity of second-line drugs and the longer treatment duration required compared with drug-susceptible TB. The efficacy of treatment for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnosis and Treatment of Multidrug-Resistant Tuberculosis

Shim TS

Despite global efforts to control tuberculosis (TB), multidrug-resistant TB (MDR-TB) is still a serious problem worldwide. The diagnosis of MDR-TB is based on mycobacterial culture followed by drug susceptibility testing,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Disseminated Multidrug-Resistant Tuberculosis involving the Brain

Jung EK, Chang JY, Lee YP, Chung MK, Seo EK, Koo HS, Choi HJ

We report a case of a 23-year-old female immigrant from China who was diagnosed with multidrug-resistant tuberculosis affecting her lung and brain, resistant to the standard first-line therapeutics and streptomycin....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Clinical Effect of Ofloxacin, Prothionamide, Cycloserine Streptomycin (Kanamycin or Tuberactinomycin) in Retreatment of Pulmonary Tuberculosis

Song JY, Yoo MK, Hong JR, Man Jeong , Kim YJ, Kim MS

  • KMID: 2317909
  • Tuberc Respir Dis.
  • 1995 Jun;42(3):295-301.
BACKGROUND: The serious problems in retreatment of pulmonary tuberculosis are a significant proportion of drug resistance. Preferably retreatment should contain the drugs which has never used before, so drug retreatment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Anti-mycobacterial Drug Susceptibility Test Results by Institutes and Methods

Oh SH, Kim YJ, Park SK, Hwang SH, Kim HH, Lee EY, Chang CL

BACKGROUND: The purposes of the current study were to evaluate the concordant rates of anti-mycobacterial drug susceptibility test (DST) results in different solid media performed in different institutes, and to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Characterization of a Toxin A-Negative, Toxin B-Positive Variant Strain of Clostridium difficile

Shin BM, Kuak EY

BACKGROUND: Clostridium difficile is one of the most important pathogens responsible for nosocomial diarrhea. Recently, we have frequently experienced culture positive, toxin A enzyme immunoassay negative strains. Therefore, we evaluated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Outcomes and Use of Therapeutic Drug Monitoring in Multidrug-Resistant Tuberculosis Patients Treated in Virginia, 2009-2014

Heysell SK, Moore JL, Peloquin C, Ashkin D, Houpt ER

BACKGROUND: Reports of therapeutic drug monitoring (TDM) for second-line medications to treat multidrug-resistant tuberculosis (MDR-TB) remain limited. METHODS: A retrospective cohort from the Virginia state tuberculosis (TB) registry, 2009-2014, was analyzed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Successful readministration of second-line antituberculous agents in a patient with near-fatal drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome

Moon SD, Won HK, Cho JY, Kang MK, Kim JY, Park HK, Kim S, Kang HR

For the treatment of multidrug-resistant (MDR) tuberculosis, maintenance of appropriate antituberculous agents is essential because of its low cure rate and high dropout rate. Drug reaction with eosinophilia and systemic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Low Serum Concentrations of Moxifloxacin, Prothionamide, and Cycloserine on Sputum Conversion in Multi-Drug Resistant TB

Lee SH, Seo KA, Lee YM, Lee HK, Kim JH, Shin C, Ghim JR, Shin JG, Kim DH

PURPOSE: Low serum concentrations of drugs used to treat multi-drug resistant tuberculosis (MDR-TB) have occasionally been associated with treatment failure. We determined the frequencies of low serum concentrations of anti-MDR-TB...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Cure with Secondary Rescue Regimen of Tuberculosis in a Patient with Tuberculous Colitis that Failed to Respond to Primary Drugs

Ko BS, Kim BG, Kim JS, Jung HC, Song IS

  • KMID: 2038327
  • Korean J Gastroenterol.
  • 2002 Apr;39(4):299-303.
Recently, the incidence of pulmonary tuberculosis has increased. In addition, extrapulmonary tuberculosis and multi-drug resistant tuberculosis have also increased. We experienced a 34-year-old male with intestinal tuberculosis which failed to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An Analysis of Antituberculosis Drug Susceptibility Test Results in Kyung Hee Medical Center During Recent Four years

Kim JH, Suh JT, Kim MH, Kim GY, Her SR, Lee HJ, Lee WI, Kang SY

  • KMID: 1892735
  • Korean J Clin Microbiol.
  • 2004 Sep;7(2):182-185.
BACKGROUND: Tuberculosis is still one of the most seriously threatening infections in Korea, because of multidrug resistant tuberculosis. Results of antituberculosis drug susceptibility test can provide clinicians very important informations...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Toxin A Enzyme Linked Fluorescence Assay and Latex Agglutination based on Clostridium difficile culture and Toxin A and B PCR assay

Shin BM, Lee EJ

  • KMID: 2224704
  • Korean J Clin Microbiol.
  • 2005 Oct;8(2):130-135.
BACKGROUND: Clostidium difficile is one of the most important pathogens responsible for nosocomial diarrhea; therefore, we compared the efficacy of laboratory tests for diagnosing C. difficile diarrhea. METHODS: We evaluated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical and Bacteriological Studies on Renal Tuberculosis

Kim JW

  • KMID: 1911257
  • Korean J Urol.
  • 1971 Dec;12(4):333-340.
Clinical study was made on 102 cases of renal tuberculosis who visited the urological department, Kyungpook University Hospital during the 4 year period from July. 1951 to June, 1970. Fourteen...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Two Enzyme Immunoassays for Clostridium difficile Toxin A

Yoo SJ, Kang JO, Oh HJ, Shin BM

BACKGROUND: Clostridium difficile is one of the most important pathogens responsible for nosocomial diarrhea. The disease is mediated by two toxins, designated as A and B; therefore, identification of the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Effects of Prothinoamide, Cycloserine, Para-Aminosalicylic Acid, Ofloxasine in Retreatment of Pulmonary Tuberculosis

Hong JR, Yoo MK, Jeong JM, Kim YJ, Son MH

BACKGROUND: Antituberculous therapy is set a short-term therpy used isoniazid(INH), rifampin(RFP), ethambutol(EMB), pyrazinamide(PZA) from 1970s' and treatment rate has been very improved. But drug interruption or irregular medication due to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacokinetics of ofloxacin in Patients with Multidrug-Resistant Tuberculosis

Park SK, Yoon YR, Lee WC, Jun HM, Shon JH, Kim KA, Park JY, Shin JG

BACKGROUND: There are few studies that have reported on the pharmacokinetic(PK) disposition of fluoroquinolones in patients with multi-drug resistant tuberculosis(MDR-Tb), even though fluoroquinolones are frequentl y co-prescribed to those patients....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Fate of Intractable Tuberculosis Cases Under National Tuberculosis Programme

Lew WJ, Lee EG, Kwon DW, Kim SJ, Hong YP, Kim JB

BACKGROUND: The natural history of bacillary tuberculosis was studied in India and results showed that at the end of the 5-year period, 49% of the patients were dead, 33% were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr